Email This Article

Headlines & Perspectives
Roche Issues Hepatitis Drug Data
By Elizabeth Trotta
11/02/07 - 06:00 PM EDT
A triple-drug combination for treatment of hepatitis C will proceed to a phase IIb trial.
Recipient's Email Address(es)
(Separate multiple addresses with a comma)
Your Email Address
Send a copy to myself
Your Message (optional)

Privacy Policy

The information entered on this page will not be used to send unsolicited email and will not be sold to a 3rd party.

Dow Jones S&P 500 NASDAQ 10-Year Note
10,282.04 1,092.56 2,168.41 33.52
Oil *
75.45
DOWN
108.07
DOWN
10.69
DOWN
21.20
DOWN
0.96
10 Yr
3.35%
SPDR Gold
112.46
-1.04%
-0.97%
-0.97%
-2.78%
Data delayed 20 minutes

Brokerage Partners